{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:25:04Z","timestamp":1791563104202,"version":"4.3.4"},"reference-count":175,"publisher":"Centers for Disease Control MMWR Office","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr7402a1","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T14:30:01Z","timestamp":1759242601000},"page":"1-33","source":"Crossref","is-referenced-by-count":24,"title":["Tularemia Antimicrobial Treatment and Prophylaxis: CDC Recommendations for Naturally Acquired Infections and Bioterrorism Response \u2014 United States, 2025"],"prefix":"10.15585","volume":"74","author":[{"given":"Christina A.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Meaney-Delman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Fleck-Derderian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Winberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R1","unstructured":"World Health Organization. WHO guidelines on tularaemia. Geneva, Switzerland: World Health Organization; 2007. https:\/\/stacks.cdc.gov\/view\/cdc\/6943"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R2","first-page":"74","article-title":"Studies on human infection with Pasteurella tularensis; comparison of streptomycin and chloramphenicol in the prophylaxis of clinical disease.","volume":"70","author":"McCrumb","year":"1957","journal-title":"Trans Assoc Am Physicians"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R3","unstructured":"CDC. About tularemia. Atlanta, GA: US Department of Health and Human Services, CDC; 2024. https:\/\/www.cdc.gov\/tularemia\/about\/index.html"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R4","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1093\/cid\/ciad736","article-title":"Systematic review: clinical features, antimicrobial treatment, and outcomes of human tularemia, 1993\u20132023.","volume":"78","author":"Nelson","year":"2024","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R5","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1086\/597261","article-title":"Molecular epidemiology of Francisella tularensis in the United States.","volume":"48","author":"Kugeler","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3201\/eid1207.051504","article-title":"Epidemiologic and molecular analysis of human tularemia, United States, 1964\u20132004.","volume":"12","author":"Staples","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R7","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1001\/jama.285.21.2763","article-title":"Tularemia as a biological weapon: medical and public health management.","volume":"285","author":"Dennis","year":"2001","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.15585\/mmwr.mm7431a3","article-title":"Notes from the field: increase in human and animal tularemia cases\u2014Minnesota, 2024.","volume":"74","author":"Bye","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R9","first-page":"328","article-title":"Tularemia.","volume":"32","author":"Harris","year":"1926","journal-title":"Colo Med"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.amjms.2018.06.006","article-title":"From squirrels to biological weapons: the early history of tularemia.","volume":"356","author":"Hirschmann","year":"2018","journal-title":"Am J Med Sci"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R11","first-page":"34","article-title":"Tularemia following injury while performing post-mortem examination of a human case. With report of the post-mortem findings in a case of pulmonic type of tularemia.","volume":"24","author":"Weilbaecher","year":"1938","journal-title":"J Lab Clin Med"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3201\/eid2504.181807","article-title":"Francisella tularensis transmission by solid organ transplantation, 2017.","volume":"25","author":"Nelson","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R13","doi-asserted-by":"publisher","first-page":"ofx027","DOI":"10.1093\/ofid\/ofx027","article-title":"Variation in tularemia clinical manifestations\u2014Arkansas, 2009\u20132013.","volume":"4","author":"Lester Rothfeldt","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R14","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1093\/cid\/ciad719","article-title":"Neuroinvasive Francisella tularensis infection: report of 2 cases and review of the literature.","volume":"78","author":"Cash-Goldwasser","year":"2024","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/23744235.2016.1222546","article-title":"Francisella tularensis endocarditis: two case reports and a literature review.","volume":"49","author":"Gaci","year":"2017","journal-title":"Infect Dis (Lond)"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R16","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1093\/cid\/ciad688","article-title":"Francisella tularensis bone and joint infections: United States, 2004\u20132023.","volume":"178","author":"Beeson","year":"2024","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fmed.2016.00009","article-title":"Keep an ear out for Francisella tularensis: otomastoiditis cases after canyoneering.","volume":"3","author":"Guerpillon","year":"2016","journal-title":"Front Med (Lausanne)"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R18","doi-asserted-by":"publisher","first-page":"1348323","DOI":"10.3389\/fmicb.2023.1348323","article-title":"Tularemia treatment: experimental and clinical data.","volume":"14","author":"Maurin","year":"2024","journal-title":"Front Microbiol"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1409.009","article-title":"Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations.","volume":"1105","author":"Sj\u00f6stedt","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3201\/eid0801.010131","article-title":"Tularemia outbreak investigation in Kosovo: case control and environmental studies.","volume":"8","author":"Reintjes","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R21","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1080\/00365540510012125","article-title":"Outbreak of tularaemia in Golcuk, Turkey in 2005: report of 5 cases and an overview of the literature from Turkey.","volume":"37","author":"Karadenizli","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R22","first-page":"61083","article-title":"Possession, use, and transfer of select agents and toxins; biennial review of the list of select agents and toxins.","volume":"77","author":"CDC","year":"2012","journal-title":"Fed Regist"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R23","unstructured":"US Department of Defense. Deseret Test Center: Red Cloud fact sheet. Washington, DC: US Department of Defense, Defense Health Agency; 2002. https:\/\/health.mil\/Reference-Center\/Fact-Sheets\/2002\/10\/09\/Red-Cloud"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R24","unstructured":"Hoffman DE. The dead hand: the untold story of the cold war arms race and its dangerous legacy. New York, NY: Doubleday; 2009."},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R25","unstructured":"World Health Organization. Tularaemia. In: Health aspects of chemical and biological weapons: report of a WHO group of consultants. 2nd ed. Geneva, Switzerland: World Health Organization; 1970:105\u20137. https:\/\/iris.who.int\/bitstream\/handle\/10665\/39444\/24039.pdf?sequence=1"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R26","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.2105\/AJPH.2018.304472","article-title":"Planning considerations for state, local, tribal, and territorial partners to receive medical countermeasures from CDC\u2019s Strategic National Stockpile during a public health emergency.","volume":"108","author":"Bhavsar","year":"2018","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R27","unstructured":"21st Century Cures Act, Pub. L. No. 114-255, 130 Stat. 1033 (Dec. 13, 2016)."},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1086\/322601","article-title":"Tularemia epidemic in northwestern Spain: clinical description and therapeutic response.","volume":"33","author":"P\u00e9rez-Castrill\u00f3n","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/00006454-200005000-00011","article-title":"Ciprofloxacin for treatment of tularemia in children.","volume":"19","author":"Johansson","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R30","unstructured":"Committee on Guidance for Establishing Crisis Standards of Care for Use in Disaster Situations; Institute of Medicine. Crisis standards of care: a systems framework for catastrophic disaster response. Washington, DC: National Academies Press; 2012. 24830057"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.su7101a1","article-title":"Standards required for the development of CDC evidence-based guidelines.","volume":"71","author":"Carande-Kulis","year":"2022","journal-title":"MMWR Suppl"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R32","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1093\/cid\/ciad686","article-title":"Systematic review of tularemia during pregnancy.","volume":"78","author":"Fleck-Derderian","year":"2024","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R33","unstructured":"CDC. Tularemia (\n                      Francisella tularensis\n                      ). National Notifiable Diseases Surveillance System (NNDSS): Atlanta, GA: US Department of Health and Human Services, CDC; 2021. https:\/\/ndc.services.cdc.gov\/conditions\/tularemia\/"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R34","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1093\/cid\/ciad689","article-title":"Tularemia clinical manifestations, antimicrobial treatment, and outcomes: an analysis of US surveillance data, 2006\u20132021.","volume":"78","author":"Wu","year":"2024","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2807\/esm.09.12.00503-en","article-title":"Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularaemia.","volume":"9","author":"Bossi","year":"2004","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R36","unstructured":"European Medicines Agency. EMA guidance document on the use of medicinal products for treatment in case of exposure to chemical agents used as weapons of terrorism, crime, or warfare. Amsterdam, Netherlands: European Medicines Agency; 2024. https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/ema-guidance-use-medicinal-products-treatment-case-exposure-chemical-agents-used-weapons-terrorism-crime-or-warfare_en.pdf"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.17886\/EpiBull-2015-017","article-title":"Tularemia\u2014a differential diagnostic challenge [German].","volume":"46","author":"Robert Koch Institute","year":"2015","journal-title":"Epidemiol Bull"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R38","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1093\/cid\/ciad668","article-title":"Efficacy of doxycycline and ciprofloxacin for treatment of pneumonic tularemia in cynomolgus macaques.","volume":"78","author":"Williams","year":"2024","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R39","article-title":"Introducing GRADE: a systematic approach to rating evidence in systematic reviews and to guideline development.","author":"Dijkers","year":"2013"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fcimb.2017.00122","article-title":"Francisella tularensis susceptibility to antibiotics: a comprehensive review of the data obtained in vitro and in animal models.","volume":"7","author":"Caspar","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R41","unstructured":"Food and Drug Administration. DDT-AMQ-000006, qualification of the cynomolgus macaque (\n                      Macaca fascicularis\n                      ) model of pneumonic tularemia. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2021. https:\/\/force-dsc.my.site.com\/ddt\/s\/ddt-project?ddtprojectid=145"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R42","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1128\/AAC.01104-12","article-title":"Consequences of delayed ciprofloxacin and doxycycline treatment regimens against Francisella tularensis airway infection.","volume":"56","author":"Rotem","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R43","doi-asserted-by":"crossref","unstructured":"Bar-Haim E, Cohen H, Ber R, Cohen O, Shafferman A. Consequences of antibiotic treatment of\n                      Francisella tularensis\n                      airways infections. In: Schafferman A, Ordentlich A, Velan B, eds. The challenge of highly pathogenic microorganisms: mechanisms of virulence and novel medical countermeasures. Dordrecht, Netherlands: Springer Netherlands; 2010:207\u201312. 10.1007\/978-90-481-9054-6_22","DOI":"10.1007\/978-90-481-9054-6_22"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R44","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/jac\/41.4.461","article-title":"The efficacy of ciprofloxacin and doxycycline against experimental tularaemia.","volume":"41","author":"Russell","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R45","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1086\/321825","article-title":"Ciprofloxacin for treatment of tularemia.","volume":"33","author":"Johansson","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R46","doi-asserted-by":"publisher","first-page":"4S","DOI":"10.4414\/SMW.2022.w30203","article-title":"Pediatric tularemia in Central Europe\u2014a case series [Abstract OC7].","volume":"152","author":"Sch\u00f6bi","year":"2022","journal-title":"Swiss Med Wkly"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R47","doi-asserted-by":"publisher","first-page":"e00612","DOI":"10.1128\/aac.00612-17","article-title":"In vitro antibiotic susceptibilities of Francisella tularensis determined by broth microdilution following CLSI methods.","volume":"61","author":"Heine","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R48","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/jac\/dkx460","article-title":"Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.","volume":"73","author":"Caspar","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/jac\/46.2.287","article-title":"In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals.","volume":"46","author":"Ik\u00e4heimo","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R50","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1128\/aac.01584-07","article-title":"In vitro susceptibility of isolates of Francisella tularensis Types A and B from North America.","volume":"52","author":"Urich","year":"2008","journal-title":"Anitmicrobial Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R51","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/cid\/ciad680","article-title":"Antimicrobial susceptibility of Francisella tularensis isolates in the United States, 2009\u20132018.","volume":"78","author":"Choat","year":"2024","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/00365540110080773","article-title":"In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis.","volume":"34","author":"Johansson","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R53","doi-asserted-by":"publisher","first-page":"6874","DOI":"10.1016\/j.vaccine.2008.09.077","article-title":"Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody.","volume":"26","author":"Klimpel","year":"2008","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R54","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1086\/520458","article-title":"Treatment of tularemia with fluoroquinolones: two cases and review.","volume":"29","author":"Limaye","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R55","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1097\/00007611-200208000-00039","article-title":"Fatal granulomatous bronchopneumonia complicated by acute renal failure.","volume":"95","author":"Onuigbo","year":"2002","journal-title":"South Med J"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R56","doi-asserted-by":"publisher","first-page":"A877","DOI":"10.1016\/j.chest.2022.08.692","article-title":"Tularemia presenting as large GI ulceration and hemorrhage.","volume":"162","author":"Baig","year":"2022","journal-title":"Chest"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R57","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ijantimicag.2006.02.006","article-title":"Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin.","volume":"27","author":"Steward","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R58","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/jac\/dki359","article-title":"In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice.","volume":"56","author":"Piercy","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R59","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fcimb.2014.00040","article-title":"New therapeutic approaches for treatment of tularaemia: a review.","volume":"4","author":"Boisset","year":"2014","journal-title":"Front Cell Infect Microbiol"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R60","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/BF01964409","article-title":"In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.","volume":"10","author":"Syrj\u00e4l\u00e4","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R61","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/0897190014546836","article-title":"Aminoglycoside-induced nephrotoxicity.","volume":"27","author":"Wargo","year":"2014","journal-title":"J Pharm Pract"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R62","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fncel.2017.00308","article-title":"Aminoglycoside-induced cochleotoxicity: a review.","volume":"11","author":"Jiang","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R63","first-page":"39","article-title":"Treatment of tularemia, including pulmonary tularemia, with gentamicin.","volume":"121","author":"Mason","year":"1980","journal-title":"Am Rev Respir Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R64","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1128\/br.30.3.542-550.1966","article-title":"Antibiotic prophylaxis and therapy of airborne tularemia.","volume":"30","author":"Sawyer","year":"1966","journal-title":"Bacteriol Rev"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R65","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1128\/AAC.01240-15","article-title":"Gallium potentiates the antibacterial effect of gentamicin against Francisella tularensis.","volume":"60","author":"Lindgren","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R66","first-page":"459","article-title":"Nonhuman primate tularemia (Francisella tularensis) epizootic in a zoological park.","volume":"24","author":"Calle","year":"1993","journal-title":"J Zoo Wildl Med"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R67","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/clinids\/19.1.42","article-title":"Streptomycin and alternative agents for the treatment of tularemia: review of the literature.","volume":"19","author":"Enderlin","year":"1994","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R68","doi-asserted-by":"publisher","first-page":"9870510","DOI":"10.1155\/2019\/9870510","article-title":"Extended-interval gentamicin dosing for pulmonic tularemia.","volume":"2019","author":"Dietrich","year":"2019","journal-title":"Case Rep Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R69","unstructured":"Jacobs RF.\n                      Francisella tularensis\n                      (Tularemia). In: Yu VL, Weber R, Raoult D, eds. Antimicrobial therapy and vaccines. 2nd ed. New York, NY: Apple Trees Productions; 2002."},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R70","first-page":"35","article-title":"Comparative study of the effectiveness of amikacin and streptomycin in experimental tularemia [Russian].","volume":"35","author":"Tinkevich","year":"1990","journal-title":"Antibiot Khimioter"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R71","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3855\/jidc.3996","article-title":"Evaluation of tularemia cases focusing on the oculoglandular form.","volume":"8","author":"Eren Gok","year":"2014","journal-title":"J Infect Dev Ctries"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R72","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/phar.2203","article-title":"Plazomicin: a next-generation aminoglycoside.","volume":"39","author":"Shaeer","year":"2019","journal-title":"Pharmacotherapy"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R73","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1358\/dof.2014.39.1.2095267","article-title":"Plazomicin.","volume":"39","author":"Galani","year":"2014","journal-title":"Drugs Future"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R74","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1586\/eri.12.25","article-title":"Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.","volume":"10","author":"Zhanel","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R75","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fmed.2019.00229","article-title":"Retrospective analysis of pneumonic tularemia in Operation Whitecoat human subjects: disease progression and tetracycline efficacy.","volume":"6","author":"Williams","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R76","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1471-2180-10-123","article-title":"Azithromycin effectiveness against intracellular infections of Francisella.","volume":"10","author":"Ahmad","year":"2010","journal-title":"BMC Microbiol"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R77","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s15010-023-02160-2","article-title":"Successful treatment of glandular tularemia with azithromycin in a pregnant woman in Austria.","volume":"52","author":"Schubert","year":"2024","journal-title":"Infection"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R78","doi-asserted-by":"publisher","first-page":"ofz413","DOI":"10.1093\/ofid\/ofz413","article-title":"Serendipitous treatment of tularemia in pregnancy.","volume":"6","author":"Johnsrud","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R79","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3201\/eid1906.130138","article-title":"Treatment of tularemia in pregnant woman, France.","volume":"19","author":"Dentan","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R80","first-page":"114","article-title":"Tularemia: a perusal of three hundred thirty-nine cases.","volume":"115","author":"Dienst","year":"1963","journal-title":"J La State Med Soc"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R81","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1093\/cid\/ciad690","article-title":"Treatment outcome of severe respiratory Type B tularemia using fluoroquinolones.","volume":"78","author":"Widerstr\u00f6m","year":"2024","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R82","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s15010-012-0355-1","article-title":"Tularemia in central Anatolia.","volume":"41","author":"Ulu-Kilic","year":"2013","journal-title":"Infection"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R83","doi-asserted-by":"publisher","first-page":"ofaa440","DOI":"10.1093\/ofid\/ofaa440","article-title":"Tularemia: a case series of patients diagnosed at the National Reference Center for Rickettsioses from 2008 to 2017.","volume":"7","author":"Darmon-Curti","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R84","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1600-0463.2008.00901.x","article-title":"Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia.","volume":"116","author":"Meric","year":"2008","journal-title":"APMIS"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R85","doi-asserted-by":"publisher","first-page":"O1042","DOI":"10.1111\/1469-0691.12741","article-title":"Evaluation of tularemia courses: a multicentre study from Turkey.","volume":"20","author":"Erdem","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R86","first-page":"391","article-title":"Clinical characteristics and effect of early treatment in tularemia cases.","volume":"32","author":"Iskender","year":"2016","journal-title":"Acta Med Mediter"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R87","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00005792-198507000-00006","article-title":"Tularemia: a 30-year experience with 88 cases.","volume":"64","author":"Evans","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R88","unstructured":"Tetracycline [Internet]. Ann Arbor, MI: Truven Health Analytics; 2025. https:\/\/www.micromedexsolutions.com\/home\/dispatch\/"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R89","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF01639529","article-title":"Influence of milk on the bioavailability of doxycycline\u2014new aspects.","volume":"17","author":"Meyer","year":"1989","journal-title":"Infection"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R90","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/clpt.1991.174","article-title":"Interference of dairy products with the absorption of ciprofloxacin.","volume":"50","author":"Neuvonen","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R91","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/00365549009023126","article-title":"A case of tularemia meningitis in Sweden.","volume":"22","author":"Hill","year":"1990","journal-title":"Scand J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R92","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/00006454-199805000-00025","article-title":"Tularemic meningitis.","volume":"17","author":"Rodgers","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R93","first-page":"1300","article-title":"Meningitis caused by Francisella tularensis [Finnish].","volume":"112","author":"Hakola","year":"1996","journal-title":"Duodecim"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R94","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/00007611-198502000-00016","article-title":"Response of tularemic meningitis to antimicrobial therapy.","volume":"78","author":"Hutton","year":"1985","journal-title":"South Med J"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R95","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/00006454-199004000-00019","article-title":"Acute bacterial meningitis caused by Francisella tularensis.","volume":"9","author":"Alfes","year":"1990","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R96","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12941-023-00642-7","article-title":"Positive Francisella tularensis meningitis outcome despite delayed identification: a case report.","volume":"22","author":"M\u00e4ki-Koivisto","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R97","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections.","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R98","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40272-013-0017-5","article-title":"Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.","volume":"15","author":"Sullins","year":"2013","journal-title":"Paediatr Drugs"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R99","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3390\/antibiotics11091193","article-title":"Tissue penetration of antimicrobials in intensive care unit patients: a systematic review\u2014part II.","volume":"11","author":"Viaggi","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R100","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/cid\/ciae093","article-title":"Central nervous system antimicrobial exposure and proposed dosing for anthrax meningitis.","volume":"78","author":"Bradley","year":"2024","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R101","unstructured":"US Environmental Protection Agency. Chemical, biological, radiological, and nuclear quick reference guides. Washington, DC: US Environmental Protection Agency; 2024. https:\/\/www.epa.gov\/emergency-response\/chemical-biological-radiological-and-nuclear-quick-reference-guides"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R102","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.15585\/mmwr.mm735152a1","article-title":"Tularemia\u2014United States, 2011\u20132022.","volume":"73","author":"Rich","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R103","unstructured":"STAKOB. Notes on the treatment and prophylaxis of tularemia [German]. Berlin, Germany: Robert Koch Institute; 2025. https:\/\/www.rki.de\/DE\/Themen\/Infektionskrankheiten\/Biologische-Gefahren\/STAKOB\/Handlungshinweise\/Stellungnahme_Tularaemie.pdf?__blob=publicationFile&v=1"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R104","first-page":"22","article-title":"Protective properties of doxycycline, rifampicin and sisomycin in experimental pulmonary tularemia of albino mice [Russian].","volume":"43","author":"D\u2019iakov","year":"1998","journal-title":"Antibiot Khimioter"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R105","doi-asserted-by":"publisher","first-page":"e00339-19","DOI":"10.1128\/JCM.00339-19","article-title":"Francisella tularensis periprosthetic joint infections diagnosed with growth in cultures.","volume":"57","author":"Chrdle","year":"2019","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R106","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1086\/313550","article-title":"Chronic prosthetic device infection with Francisella tularensis.","volume":"29","author":"Cooper","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R107","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1089\/vbz.2010.0227","article-title":"Arthropod-borne tularemia in Poland: a case report.","volume":"11","author":"Moniuszko","year":"2011","journal-title":"Vector Borne Zoonotic Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R108","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1128\/JCM.40.6.2278-2281.2002","article-title":"Exposure of laboratory workers to Francisella tularensis despite a bioterrorism procedure.","volume":"40","author":"Shapiro","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R109","doi-asserted-by":"crossref","unstructured":"Corbel M.\n                      Yersinia, Pasteurella\n                      and\n                      Francisella\n                      [Chapter 35]. In: Greenwood D, Barer M, Slack R, Irving W, eds. Medical microbiology. London, UK: Churchill Livingstone Elsevier; 2012:350\u20138.","DOI":"10.1016\/B978-0-7020-4089-4.00050-0"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R110","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/zph.12552","article-title":"Human tularaemia associated with exposure to domestic dogs\u2014United States, 2006\u20132016.","volume":"66","author":"Kwit","year":"2019","journal-title":"Zoonoses Public Health"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R111","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1093\/cid\/ciad687","article-title":"Tularemia from veterinary occupational exposure.","volume":"78","author":"Marx","year":"2024","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R112","doi-asserted-by":"publisher","first-page":"731","DOI":"10.15585\/mmwr.mm73333a3","article-title":"Notes from the field: tularemia associated with harbor seal necropsy\u2014Kitsap County, Washington, October 2023.","volume":"73","author":"Inouye","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R113","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s15010-013-0456-5","article-title":"Tularemia during pregnancy.","volume":"41","author":"Ata","year":"2013","journal-title":"Infection"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R114","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/00000441-194712000-00011","article-title":"Tularemia treated with streptomycin.","volume":"214","author":"Johnson","year":"1947","journal-title":"Am J Med Sci"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R115","first-page":"165","article-title":"Congenital tularemia.","volume":"43","author":"Lide","year":"1947","journal-title":"Arch Pathol (Chic)"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R116","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/1471-0528.15119","article-title":"The safety of quinolones and fluoroquinolones in pregnancy: a meta-analysis.","volume":"125","author":"Yefet","year":"2018","journal-title":"BJOG"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R117","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11095-018-2383-8","article-title":"Pregnancy outcomes following exposure to quinolone antibiotics\u2014a systematic-review and meta-analysis.","volume":"35","author":"Ziv","year":"2018","journal-title":"Pharm Res"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R118","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.reprotox.2019.02.002","article-title":"Pregnancy outcomes following quinolone and fluoroquinolone exposure during pregnancy: a systematic review and meta-analysis.","volume":"85","author":"Acar","year":"2019","journal-title":"Reprod Toxicol"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R119","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1093\/cid\/ciz1231","article-title":"Safety of antimicrobials during pregnancy: a systematic review of antimicrobials considered for treatment and postexposure prophylaxis of plague.","volume":"70","author":"Yu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R120","doi-asserted-by":"publisher","first-page":"e2445055","DOI":"10.1001\/jamanetworkopen.2024.45055","article-title":"First trimester tetracycline exposure and risk of major congenital malformations.","volume":"7","author":"Nakitanda","year":"2024","journal-title":"JAMA Netw Open"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R121","doi-asserted-by":"publisher","first-page":"E625","DOI":"10.1503\/cmaj.161020","article-title":"Use of antibiotics during pregnancy and risk of spontaneous abortion.","volume":"189","author":"Muanda","year":"2017","journal-title":"CMAJ"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R122","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1111\/bcp.13364","article-title":"Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study.","volume":"83","author":"Muanda","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pds.5891","article-title":"Risk of pregnancy loss after prenatal exposure to doxycycline: a retrospective cohort study [Abstract 57].","volume":"33","author":"Hung-Kai","year":"2024","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R124","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","article-title":"Committee opinion no. 713: antenatal corticosteroid therapy for fetal maturation.","volume":"130","author":"Committee on Obstetric Practice","year":"2017","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R125","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1086\/588843","article-title":"Tularemia with vesicular skin lesions may be mistaken for infection with herpes viruses.","volume":"47","author":"Byington","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R126","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/vbz.2012.1184","article-title":"Unusual presentation of oropharyngeal tularem\u0131a: a case report.","volume":"13","author":"Polat","year":"2013","journal-title":"Vector Borne Zoonotic Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R127","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/jpids\/piaa066","article-title":"Disseminated tularemia: finding the needle in the haystack.","volume":"10","author":"Stringham","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R128","first-page":"365","article-title":"Chasing fever of unknown origin into the rabbit hole [Abstract].","volume":"66","author":"Clark","year":"2018","journal-title":"J Investig Med"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R129","first-page":"137","article-title":"Tularaemia: rare cause of fever and lymphadenopathy in an infant [Czech].","volume":"63","author":"Janda","year":"2008","journal-title":"Ces-slov Pediat"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R130","doi-asserted-by":"publisher","first-page":"184","DOI":"10.17161\/kjm.vol1415208","article-title":"An 8-month-old girl with prolonged fever.","volume":"14","author":"Abdo","year":"2021","journal-title":"Kans J Med"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R131","first-page":"41","article-title":"Considerations on tularemia, with the contribution of a personal case [Italian].","volume":"30","author":"Ferlini","year":"1978","journal-title":"G Mal Infett Parassit"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R132","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3109\/00365548.2012.720027","article-title":"Tularemia during pregnancy: report of four cases.","volume":"45","author":"Ye\u015filyurt","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R133","unstructured":"Bayer Pharmaceuticals. Cipro (ciprofloxacin oral suspension) [Package insert]. West Haven, CT: Bayer Pharmaceuticals; 2007."},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R134","first-page":"103","article-title":"On the epidemiology of tularemia based on observations in Lower Austria [German].","volume":"59","author":"Puntigam","year":"1947","journal-title":"Wien Klin Wochenschr"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7003a1","article-title":"Antimicrobial treatment and prophylaxis of plague: recommendations for naturally acquired infections and bioterrorism response.","volume":"70","author":"Nelson","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R136","unstructured":"Tetracycline. In: Drugs and lactation database (LactMed) [Internet]. Bethesda, MD: National Institute of Child Health and Human Development; 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501108\/"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R137","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1046\/j.1365-2133.1996.134869.x","article-title":"Black breast milk due to minocycline therapy.","volume":"134","author":"Hunt","year":"1996","journal-title":"Br J Dermatol"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R138","unstructured":"Azithromycin. In: Drugs and lactation database (LactMed) [Internet]. Bethesda, MD: National Institute of Child Health and Human Development; 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501200\/"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R139","unstructured":"Chloramphenicol. In: Drugs and lactation database (LactMed) [Internet]. Bethesda, MD: National Institute of Child Health and Human Development; 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501494\/"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R140","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1093\/cid\/cis706","article-title":"Clinical recognition and management of tularemia in Missouri: a retrospective records review of 121 cases.","volume":"55","author":"Weber","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R141","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2165\/11531490-000000000-00000","article-title":"Safety considerations of fluoroquinolones in the elderly: an update.","volume":"27","author":"Stahlmann","year":"2010","journal-title":"Drugs Aging"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R142","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.clinthera.2014.09.020","article-title":"Neurotoxicity with antimicrobials in the elderly: a review.","volume":"36","author":"Mattappalil","year":"2014","journal-title":"Clin Ther"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R143","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1161\/CIR.0000000000000905","article-title":"Drug-induced arrhythmias: a scientific statement from the American Heart Association.","volume":"142","author":"Tisdale","year":"2020","journal-title":"Circulation"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R144","doi-asserted-by":"publisher","first-page":"161","DOI":"10.18773\/austprescr.2021.035","article-title":"Fluoroquinolone antibiotics and adverse events.","volume":"44","author":"Baggio","year":"2021","journal-title":"Aust Prescr"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R145","unstructured":"Levofloxacin. Ann Arbor, MI: Truven Health Analytics; 2025. https:\/\/www.micromedexsolutions.com\/home\/dispatch\/"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R146","unstructured":"Ciprofloxacin & levofloxacin. Adverse effects. Greenwood Village, CO: Truven Health Analytics; 2025. https:\/\/www.micromedexsolutions.com\/home\/dispatch"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R147","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1517\/14740338.7.5.571","article-title":"The use and safety of doxycycline hyclate and other second-generation tetracyclines.","volume":"7","author":"Sloan","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R148","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults.","volume":"71","author":"2023 American Geriatrics Society Beers Criteria Update Expert Panel","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R149","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/IDR.S53700","article-title":"Host-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity.","volume":"7","author":"Steiner","year":"2014","journal-title":"Infect Drug Resist"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R150","unstructured":"CDC. Vaccines & immunizations: altered immunocompetence. Atlanta, GA: US Department of Health and Human Services, CDC; 2023. https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-best-practices\/altered-immunocompetence.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/immunocompetence.html"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R151","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.3390\/microorganisms9122539","article-title":"Host immunity and Francisella tularensis: a review of tularemia in immunocompromised patients.","volume":"9","author":"Bahuaud","year":"2021","journal-title":"Microorganisms"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R152","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/phar.2023","article-title":"Comprehensive guidance for antibiotic dosing in obese adults.","volume":"37","author":"Meng","year":"2017","journal-title":"Pharmacotherapy"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R153","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1017\/S0963180103124164","article-title":"Ethical resource distribution after biological, chemical, or radiological terrorism.","volume":"12","author":"Iserson","year":"2003","journal-title":"Camb Q Healthc Ethics"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R154","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/08404704211047911","article-title":"Ethics of resource allocation in a public health emergency context.","volume":"34","author":"Steele","year":"2021","journal-title":"Healthc Manage Forum"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R155","first-page":"1202","article-title":"Tularemia associated with a hamster bite\u2014Colorado, 2004.","volume":"53","author":"CDC","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R156","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1093\/cid\/ciad669","article-title":"Confirmed case of longstanding respiratory Francisella tularensis holarctica infection: Nebraska, 2022.","volume":"78","author":"Birn","year":"2024","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R157","doi-asserted-by":"publisher","first-page":"ofz499","DOI":"10.1093\/ofid\/ofz499","article-title":"Lack of tularemia among health care providers with close contact with infected patients\u2014a case series.","volume":"7","author":"Nelson","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R158","unstructured":"The Public Health Agency of Sweden. Rabbit fever\u2014disease statistics [Swedish]. Solna, Sweden: The Public Health Agency of Sweden; 2023. https:\/\/www.folkhalsomyndigheten.se\/folkhalsorapportering-statistik\/statistik-a-o\/sjukdomsstatistik\/harpest\/?tab=tab-report"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R159","doi-asserted-by":"crossref","unstructured":"Garner JS; Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Atlanta, GA: US Department of Health and Human Services, CDC; 1996. https:\/\/stacks.cdc.gov\/view\/cdc\/23188","DOI":"10.1086\/647190"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R160","unstructured":"CDC. Infection control. Summary of recommendations in the guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings (2007). Atlanta, GA: US Department of Health and Human Services, CDC; 2007. https:\/\/www.cdc.gov\/infection-control\/hcp\/isolation-precautions\/summary-recommendations.html"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R161","unstructured":"Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Atlanta, GA: US Department of Health and Human Services, CDC; 2024. https:\/\/www.cdc.gov\/infection-control\/media\/pdfs\/Guideline-Isolation-H.pdf"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R162","unstructured":"CDC. CDC\u2019s core infection prevention and control practices for safe healthcare delivery in all settings. Atlanta, GA: US Department of Health and Human Services, CDC; 2024. https:\/\/www.cdc.gov\/infection-control\/hcp\/core-practices\/index.html"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R163","unstructured":"National Response Team. NRT quick reference guide:\n                      Francisella tularensis\n                      (causes the disease tularemia). Washington, DC: US Environmental Protection Agency, National Response Team; 2011. https:\/\/nrt.response.epa.gov\/sites\/2\/files\/120502_Tularemia_QRG_Final.pdf"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R164","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/IPC.0b013e318234c383","article-title":"Laboratory-acquired tularemia successfully treated with ciprofloxacin: a case report.","volume":"20","author":"Lam","year":"2012","journal-title":"Infect Dis Clin Pract"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R165","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/0002-9343(61)90214-5","article-title":"An analysis of forty-two cases of laboratory-acquired tularemia. Treatment with broad spectrum antibiotics.","volume":"30","author":"Overholt","year":"1961","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R166","doi-asserted-by":"publisher","first-page":"621","DOI":"10.7326\/0003-4819-50-3-621","article-title":"Laboratory-acquired tularemia in vaccinated individuals: a report of 62 cases.","volume":"50","author":"Van Metre","year":"1959","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R167","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/qjmed\/os-17.68.365","article-title":"Tularemia in man from laboratory infection.","volume":"os-17","author":"Ledingham","year":"1924","journal-title":"QJM"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R168","first-page":"1731","article-title":"Tularaemia Francis 1921: VII. Six cases of tular\u00e6mia occurring in laboratory workers.","volume":"36","author":"Lake","year":"1921","journal-title":"Public Health Rep"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R169","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1128\/CMR.8.3.389","article-title":"Laboratory-associated infections and biosafety.","volume":"8","author":"Sewell","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R170","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaci.2006.01.044","article-title":"Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination.","volume":"117","author":"Fuller","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R171","unstructured":"CDC. Tularemia: clinical care of tularemia. Atlanta, GA: US Department of Health and Human Services, CDC; 2024. https:\/\/www.cdc.gov\/tularemia\/hcp\/clinical-care\/index.html"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R172","first-page":"719","article-title":"Drugs and vaccines against biological weapons.","volume":"65","year":"2001","journal-title":"Conn Med"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R173","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fcimb.2018.00154","article-title":"Live attenuated tularemia vaccines for protection against respiratory challenge with virulent F. tularensis subsp. tularensis.","volume":"8","author":"Jia","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R174","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12223-016-0461-z","article-title":"Tularemia vaccines.","volume":"61","author":"Putzova","year":"2016","journal-title":"Folia Microbiol (Praha)"},{"key":"key-10.15585\/mmwr.rr7402a1-202509301029-R175","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/VDT.S85545","article-title":"Tularemia vaccine development: paralysis or progress?","volume":"6","author":"Sunagar","year":"2016","journal-title":"Vaccine (Auckl)"}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T14:30:11Z","timestamp":1759242611000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/74\/rr\/rr7402a1.htm?s_cid=rr7402a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":175,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,2]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr7402a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,2]]},"published":{"date-parts":[[2025,10,2]]}}}